Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
4.580
-0.060 (-1.29%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Exagen Employees
As of December 31, 2025, Exagen had 220 total employees, including 216 full-time and 4 part-time employees. The number of employees increased by 5 or 2.33% compared to the previous year.
Employees
220
Change (1Y)
5
Growth (1Y)
2.33%
Revenue / Employee
$310,832
Profits / Employee
-$91,664
Market Cap
110.65M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| Castle Biosciences | 942 |
| Burning Rock Biotech | 667 |
| MDxHealth | 364 |
| Biodesix | 334 |
| Personalis | 260 |
XGN News
- 4 days ago - Roth starts Exagen at Buy, notes biomarker testing outperformance - TheFly
- 4 days ago - Exagen initiated with a Buy at Roth Capital - TheFly
- 4 weeks ago - Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus - GlobeNewsWire
- 6 weeks ago - Exagen price target lowered to $8 from $9 at BTIG - TheFly
- 6 weeks ago - Exagen reports Q1 EPS (17c), consensus (25c) - TheFly
- 6 weeks ago - Exagen backs FY26 revenue view $70M-$73M, consensus $71.27M - TheFly
- 7 weeks ago - Exagen Earnings Call Transcript: Q1 2026 - Transcripts
- 7 weeks ago - Exagen Earnings release: Q1 2026 - Filings